Literature DB >> 30318995

Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease.

J C Chang1,2, R Xiao1, L Mercer-Rosa3,4, A M Knight2,5,4, P F Weiss2,5,6.   

Abstract

OBJECTIVES: There are no population-based estimates of the incidence or risk factors for acute cardiac manifestations in children with systemic lupus erythematosus (SLE) to guide screening and diagnostic imaging practices. We estimated the incidence and prevalence of acute cardiac manifestations of child-onset SLE compared to adult-onset SLE and identified factors associated with cardiac diagnoses.
METHODS: We identified children (5-17 years) and adults (18-64 years) with incident SLE (≥3 International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9 CM) code 710.0, > 30 days apart) using Clinformatics® DataMart (OptumInsight, Eden Prairie, MN) deidentified United States administrative claims (2000-2013). We calculated incidence and prevalence of three outcomes: ≥ 1 diagnosis code for (1) pericarditis and/or myocarditis, (2) endocarditis, or (3) valvular insufficiency. Negative binomial regression was used to identify characteristics associated with cardiac diagnoses in children and determine whether SLE onset in childhood vs adulthood was independently associated with cardiac involvement.
RESULTS: There were 297 children and 6927 adults with new-onset SLE. A total of 17.8% of children had ICD-9 CM codes for acute cardiac diagnoses, the incidence of which were highest in the first year after SLE diagnosis (12.2 per 100 person-years). African American race (incidence rate ratio (IRR) 6.6, 95% confidence interval (CI) (2.9, 15.0), p < 0.01) and nephritis (IRR 7.0, 95% CI (2.6, 18.6), p < 0.01) were associated with acute cardiac diagnoses in children. Child-onset disease was independently associated with a 4.4-fold higher rate of pericarditis or myocarditis compared to adult-onset SLE after adjustment for other disease and demographic characteristics (95% CI (2.4, 8.0), p < 0.01).
CONCLUSION: This study establishes baseline estimates of the incidence and prevalence of pericarditis and myocarditis in child-onset SLE, which is substantially higher than that of adult-onset SLE. Prospective echocardiographic evaluations are needed to validate incidence measures and characterize the natural history of acute cardiac manifestations in child-onset SLE, as well as identify risk factors for poor cardiac outcomes to inform screening and management.

Entities:  

Keywords:  Pediatric systemic lupus erythematosus; cardiovascular diseases; systemic lupus erythematosus

Mesh:

Year:  2018        PMID: 30318995      PMCID: PMC6207474          DOI: 10.1177/0961203318804889

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  29 in total

1.  Identification and validation of lupus nephritis cases using administrative data.

Authors:  L B Chibnik; E M Massarotti; K H Costenbader
Journal:  Lupus       Date:  2010-02-23       Impact factor: 2.911

Review 2.  Myocarditis in systemic lupus erythematosus.

Authors:  Mevan Wijetunga; Stanley Rockson
Journal:  Am J Med       Date:  2002-10-01       Impact factor: 4.965

Review 3.  A systematic review of validated methods to capture myopericarditis using administrative or claims data.

Authors:  Rachel T Idowu; Ryan Carnahan; Nila A Sathe; Melissa L McPheeters
Journal:  Vaccine       Date:  2013-12-30       Impact factor: 3.641

4.  Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus.

Authors:  Rafael Hennemann Sassi; Jordana Vaz Hendler; Giovana Fagundes Piccoli; Andrese Aline Gasparin; Rafael Mendonça da Silva Chakr; João Carlos Tavares Brenol; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2016-11-17       Impact factor: 2.980

5.  Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study.

Authors:  Felix Perez-Villa; Josep Font; Manel Azqueta; Gerard Espinosa; Carles Pare; Ricard Cervera; Joan C Reverter; Miguel Ingelmo; Gines Sanz
Journal:  Arthritis Rheum       Date:  2005-06-15

6.  Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.

Authors:  Linda T Hiraki; Susanne M Benseler; Pascal N Tyrrell; Diane Hebert; Elizabeth Harvey; Earl D Silverman
Journal:  J Pediatr       Date:  2007-11-05       Impact factor: 4.406

7.  Cardiac involvement in systemic lupus erythematosus detected by echocardiography.

Authors:  I G Crozier; E Li; M J Milne; M G Nicholls
Journal:  Am J Cardiol       Date:  1990-05-01       Impact factor: 2.778

8.  Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome.

Authors:  L B Tucker; S Menon; J G Schaller; D A Isenberg
Journal:  Br J Rheumatol       Date:  1995-09

9.  Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients.

Authors:  E Badui; D Garcia-Rubi; E Robles; J Jimenez; L Juan; M Deleze; A Diaz; G Mintz
Journal:  Angiology       Date:  1985-07       Impact factor: 3.619

10.  Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.

Authors:  Hermine I Brunner; Dafna D Gladman; Dominique Ibañez; Murray D Urowitz; Earl D Silverman
Journal:  Arthritis Rheum       Date:  2008-02
View more
  10 in total

1.  A population-based study of risk factors for heart failure in pediatric and adult-onset systemic lupus erythematosus.

Authors:  Joyce C Chang; Rui Xiao; Andrea M Knight; Stephen E Kimmel; Laura M Mercer-Rosa; Pamela F Weiss
Journal:  Semin Arthritis Rheum       Date:  2020-05-03       Impact factor: 5.532

2.  Diagnostic dilemma in a 3-year-old girl with acute nephritic syndrome and hematologic abnormalities: Answers.

Authors:  Samantha Innocenti; Silvia Bernardi; Maud Prévot; Antonin Saldmann; Maud Tusseau; Alexandre Belot; Jean-Paul Duong Van Huyen; Olivia Boyer
Journal:  Pediatr Nephrol       Date:  2022-10-17       Impact factor: 3.651

Review 3.  A Contemporary Update on the Diagnosis of Systemic Lupus Erythematosus.

Authors:  Xin Huang; Qing Zhang; Huilin Zhang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-22       Impact factor: 8.667

4.  Pediatric systemic lupus erythematosus patients in South Africa have high prevalence and severity of cardiac and vascular manifestations.

Authors:  Michael J Harrison; Liesl J Zühlke; Laura B Lewandowski; Christiaan Scott
Journal:  Pediatr Rheumatol Online J       Date:  2019-11-26       Impact factor: 3.054

Review 5.  Recurrent Pericarditis in Children and Adolescents.

Authors:  Enrico Tombetti; Teresa Giani; Antonio Brucato; Rolando Cimaz
Journal:  Front Pediatr       Date:  2019-10-18       Impact factor: 3.418

Review 6.  Epidemiological Impact of Myocarditis.

Authors:  Ainoosh Golpour; Dimitri Patriki; Paul J Hanson; Bruce McManus; Bettina Heidecker
Journal:  J Clin Med       Date:  2021-02-05       Impact factor: 4.241

Review 7.  The potential role of Colchicine in preventing coronary vascular disease in childhood-onset lupus: a new view on an old drug.

Authors:  Dori Abel; Stacy P Ardoin; Mark Gorelik
Journal:  Pediatr Rheumatol Online J       Date:  2021-02-16       Impact factor: 3.054

8.  Pediatric Lupus Presenting as Pulmonary Hypertension, Myocarditis, and Massive Pericardial Effusion in an 11-Year-Old Girl: A Case Report and Literature Review.

Authors:  Yu-Jhen Chen; Ying-Jui Lin; Mindy Ming-Huey Guo
Journal:  Front Pediatr       Date:  2022-01-26       Impact factor: 3.418

9.  Leukocyte Telomere Length and Childhood Onset of Systemic Lupus Erythematosus in the Black Women's Experiences Living with Lupus Study.

Authors:  John Bridges; Kara W Chung; Connor D Martz; Emily A Smitherman; Cristina Drenkard; Calvin Wu; Jue Lin; S Sam Lim; David H Chae
Journal:  ACR Open Rheumatol       Date:  2022-02-17

Review 10.  The spectrum of lupus myocarditis: from asymptomatic forms to cardiogenic shock.

Authors:  Maya Guglin; Carson Smith; Roopa Rao
Journal:  Heart Fail Rev       Date:  2020-11-19       Impact factor: 4.214

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.